BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7876335)

  • 1. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.
    Reddy KB; Hocevar BA; Howe PH
    J Cell Biochem; 1994 Nov; 56(3):418-25. PubMed ID: 7876335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
    Zhang F; Taipale M; Heiskanen A; Laiho M
    Oncogene; 2001 Sep; 20(41):5888-96. PubMed ID: 11593394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells.
    Mal A; Poon RY; Howe PH; Toyoshima H; Hunter T; Harter ML
    Nature; 1996 Mar; 380(6571):262-5. PubMed ID: 8637577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Cdk inhibitors restore TGF-beta sensitivity in cdk4 overexpressing epithelial cells.
    Soni R; Fretz H; Muller L; Schoepfer J; Chaudhuri B
    Biochem Biophys Res Commun; 2000 Jun; 272(3):794-800. PubMed ID: 10860833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase.
    Kleinberger-Doron N; Shelah N; Capone R; Gazit A; Levitzki A
    Exp Cell Res; 1998 Jun; 241(2):340-51. PubMed ID: 9637776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
    Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A; Massagué J
    Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription.
    Alexandrow MG; Moses HL
    Cancer Res; 1995 Sep; 55(17):3928-32. PubMed ID: 7641212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells.
    Fautsch MP; Eblen ST; Anders RA; Burnette RJ; Leof EB
    J Cell Biochem; 1995 Aug; 58(4):517-26. PubMed ID: 7593274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells.
    Ko TC; Sheng HM; Reisman D; Thompson EA; Beauchamp RD
    Oncogene; 1995 Jan; 10(1):177-84. PubMed ID: 7824270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
    Ando K; Griffin JD
    Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
    Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
    Münger K; Pietenpol JA; Pittelkow MR; Holt JT; Moses HL
    Cell Growth Differ; 1992 May; 3(5):291-8. PubMed ID: 1633111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.
    Koff A; Ohtsuki M; Polyak K; Roberts JM; Massagué J
    Science; 1993 Apr; 260(5107):536-9. PubMed ID: 8475385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin E and cyclin A as candidates for the restriction point protein.
    Dou QP; Levin AH; Zhao S; Pardee AB
    Cancer Res; 1993 Apr; 53(7):1493-7. PubMed ID: 8384078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
    Tsai LH; Lees E; Faha B; Harlow E; Riabowol K
    Oncogene; 1993 Jun; 8(6):1593-602. PubMed ID: 8502482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
    Zhang F; Mönkkönen M; Roth S; Laiho M
    Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.